High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer Read More » November 25, 2024
FDA Awards Orphan Drug Designation to Avutometinib Plus Defactinib in Pancreatic Cancer Read More » August 7, 2024
FDA Grants Fast Track Designation to VCN-01 in Metastatic Pancreatic Cancer Read More » May 23, 2024
